期刊文献+

固体分散技术的研究进展 被引量:9

下载PDF
导出
摘要 固体分散技术是指制备制剂时固体药物,特别是难溶性药物的分散技术,具体来说就是药物以分子、胶体、无定型或微晶状态均匀分散在某一固体载体中所形成的分散体系[1].制剂中药物的释放和吸收与药物的分散状态具有相关关系,我们经常通过改变剂型、工艺等方法来改变药物的分散状态,从而得到药物高效、缓释或者提高生物利用度的目的.1961年,Sekiguchi等[2]首先以尿素为载体,用熔融法制备了磺胺噻唑固体分散体.结果表明,该分散体能够提高磺胺噻唑的水溶性和生物利用度.近年来,随着各种不同功能的载体以及新技术引入到固体分散技术中,固体分散技术的研究进入了新的发展阶段.
机构地区 北京中医药大学
出处 《中国民间疗法》 2012年第8期78-79,共2页 China's Naturopathy
  • 相关文献

参考文献16

  • 1平其能.现代药剂学.北京:中国医药科技出版社,2009:66-74. 被引量:1
  • 2Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. La comparsion of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull, 1961, 9 ( 11 ) 866-869. 被引量:1
  • 3尹崇道.蒿甲醚固体分散体缓释制剂的研制及其体外溶出度的观察[J].中国药房,1997,8(6):252-252. 被引量:14
  • 4I.aw S L, Lo W Y, Lin F M, et al. Dissolution and absorption of nifedipine in polyethylene glycol solid dispersion containing, phosphatidylcholine, Int J Pharm, 1992,84 : 161. 被引量:1
  • 5Najib N,Suleiman S M. The kinetics of drug release from ethylcellu- lose solid dispersion. Drug, Dev Ind Pharm, 1985,11 (12) : 2169. 被引量:1
  • 6Oth MP, Moes AJ. Sustained release solid dispersions of indomethacin with eudragit RS and RL. Int J Pharm,1989,55:157. 被引量:1
  • 7Liu S K,Zhong,Y Q,Sun O R,et al. Study on sustained release solid dispersion of nicardipine hydroehloride. Chin J Pharm, 2000, 31 (3) :107. 被引量:1
  • 8Haseguwa A, Nakigawa H. Application of solid dispersions of Niledip- ine with enteric coating agent to prepare sustained-release dosage form. Chem Pharm Bu11,1995,33(4):1615. 被引量:1
  • 9Verreck G, Chun I, Petters J, et al. Preparation and characterization of nanofibers containing, amorphous drug, dispersions generated by e- lectronic spinning. Pharm Res,2003,20(5) :810-817. 被引量:1
  • 10Rodier E, LochardH, Sauceau M, et al. A three step supercritical process to improve the dissolution rate of Eflucimibe. Eur J Pharm Sci, 2005, 26(2) :184-193. 被引量:1

二级参考文献21

  • 1Verreck G, Chun I,Peeters J, et al. Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning [ J ]. Pharm Res,2003,20(5) :810 - 817. 被引量:1
  • 2Dannenfelser RM, He H, Joshi Y, et al. Development of clinical dosage forms for a poorly water soluble drug Ⅰ : application of polyethylene glycol-polysorbate 80 solid dispersioncartier system[J]. J Pharm Sci ,2004,93(5) : 1165 - 1175. 被引量:1
  • 3Serajuddin AT. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs[J]. J Pharm Sci, 1999, 88(10): 1058 -1066. 被引量:1
  • 4Verreck G, Vandecruys R, De Conde V, et al. The use of three different solid dispersion formulations-melt extrusion,film-coated beads, and a glass thermoplastic system-to improve the bioavailability of a nova] microsomal triglyceride transfer protein inhibitor [ J ]. J Pharm Sci, 2004, 93 ( 5 ):1217- 1228. 被引量:1
  • 5Verheyen S, Blaton N, Kinget R, et al. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 sohd dispersions[ J]. Int J Phann,2002, 249(1 - 2) :45 - 58. 被引量:1
  • 6Kushida I, Ichikawa M, Asakawa N. Improvement of dissolution and oral absorption of ER-34122, a poorly water-solubledual 5-hpoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion [J ]. J Pharm Sci ,2002,91(1) :258 - 266. 被引量:1
  • 7Craig DQ. The mechanisms of drug release from solid dispersion in water-soluble polymers[ J]. Int J Pharm, 2002,231(2) : 131 - 144. 被引量:1
  • 8Lloyd GR, Craig DQ, Smith A. A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions[J]. Ear J Pharm Biopharm, 1999, 48(1):59-65. 被引量:1
  • 9Matsumoto T,Zografi G.Physical properties of solid molecular dispersions of indomethacin with poly (vinylpyrrolidone)and poly(vinylpyrrohdone-co-vinyl-acetale) in relation to indomethacin crystallization[ J]. Pharm Res, 1999, 16( 11 ):1722- 1728. 被引量:1
  • 10Van den Mooter G,Wuyts M,Blaton N, et al . Physical stabilization of amorphous ketoconazole in sofid dispersions with polyvinylpyrrolidone K25 [ J ]. Eur J Pharm Sci, 2001, 12(3) :261 - 269. 被引量:1

共引文献32

同被引文献157

引证文献9

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部